Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04971564

Thrombo-inflammation Biomarkers Trial in Acute Cerebral Hypoxia

Thrombo-inflammation Biomarkers Trial in Acute Cerebral Hypoxia. A Case-control Trial Nested in a Cohort

Status
Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this trial is to study, in three well-defined clinical situations responsible for cerebral hypoxia, the concentrations of biomarkers of thrombo-inflammation compared to a population of patients without cerebral hypoxia, and to study in patients with cerebral hypoxia the association between these concentrations and the clinical evolution.

Conditions

Interventions

TypeNameDescription
OTHERBlood samplingBlood sampling will be made to Day 0, Day 3 and to 3 month after inclusion

Timeline

Start date
2024-03-19
Primary completion
2026-06-22
Completion
2026-06-22
First posted
2021-07-21
Last updated
2026-01-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04971564. Inclusion in this directory is not an endorsement.

Thrombo-inflammation Biomarkers Trial in Acute Cerebral Hypoxia (NCT04971564) · Clinical Trials Directory